{"gene":"HCN4","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2011,"finding":"Cardiac-specific, inducible knockout of HCN4 in adult mice causes severe bradycardia (~50% rate reduction), AV block, and death within ~5 days, with ~70% reduction of If current in sinoatrial node myocytes, establishing HCN4 as essential for normal cardiac impulse generation and conduction.","method":"Inducible cardiac-specific Cre-lox knockout mouse model; in vitro patch-clamp of isolated SAN myocytes; immunofluorescence and Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — cardiac-specific KO with defined electrophysiological and in vivo phenotypes, multiple orthogonal methods (patch-clamp, immunofluorescence, Western blot, telemetric ECG)","pmids":["21220308"],"is_preprint":false},{"year":2003,"finding":"HCN4 and HCN1 co-assemble into heteromeric channels in heterologous expression; the HCN4-HCN1 (4-1) tandem construct produces activation kinetics intermediate between the two homomers, approaching those of native rabbit SAN If current, suggesting both isoforms contribute to native f-channels.","method":"Heterologous co-expression in HEK293 cells; tandem-linked constructs; whole-cell patch-clamp; comparison with native SAN If","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with tandem constructs in single lab; cAMP sensitivity of co-transfected channels did not fully recapitulate native channel, leaving uncertainty","pmids":["12702747"],"is_preprint":false},{"year":2001,"finding":"HCN4 channels expressed in taste cells are gated by extracellular protons: lowering pH causes a dose-dependent shift in the activation curve to more positive voltages, mediating sour taste transduction.","method":"In situ hybridization; immunohistochemistry in rat vallate papilla; whole-cell patch-clamp of taste cells; voltage-clamp of HCN channels","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct electrophysiology demonstrating proton gating of HCN channels in native taste cells plus heterologous expression; published in high-impact journal with orthogonal methods","pmids":["11675786"],"is_preprint":false},{"year":2004,"finding":"The D553N missense mutation in HCN4 causes a trafficking defect that reduces membrane expression and If current in a dominant-negative manner, establishing loss-of-function via protein trafficking impairment as a mechanism for sinus node dysfunction.","method":"In vitro expression in HEK293 cells; patch-clamp; biotinylation assay; Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (patch-clamp, surface biotinylation, Western blot) in single lab; mechanistic detail on trafficking defect","pmids":["15123648"],"is_preprint":false},{"year":2003,"finding":"KCNE2 co-expressed with HCN4 enhances current amplitude, slows activation kinetics, and shifts half-maximal activation to more negative voltages; the C-terminal tail of KCNE2 (but not KCNE1, KCNE3, or KCNE4) directly interacts with the C-terminal tail of HCN4 as shown by yeast two-hybrid.","method":"Co-expression in Xenopus oocytes and CHO cells; two-electrode voltage-clamp and patch-clamp; yeast two-hybrid interaction assay","journal":"Pflugers Archiv : European journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal functional and protein-interaction data with two cell systems; single lab","pmids":["12856183"],"is_preprint":false},{"year":2010,"finding":"The crystal structure of the C-terminal fragment of human HCN4 (C-linker + CNBD) at 2.4 Å reveals high similarity to mouse HCN2 but with distinct residues in the β4-β5 loop that account for HCN4's ~3-fold reduced cAMP response and prolonged deactivation upon cAMP binding compared to HCN2.","method":"X-ray crystallography at 2.4 Å; mutagenesis; electrophysiology (patch-clamp)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure combined with mutagenesis and functional electrophysiology in single study; multiple orthogonal methods","pmids":["20829353"],"is_preprint":false},{"year":2010,"finding":"PKA directly phosphorylates HCN4 at ≥13 sites (≥3 N-terminal, ≥10 C-terminal) identified by in vitro phosphorylation assay and mass spectrometry; a PKA regulatory site in the distal C-terminus is required for PKA-mediated shift of HCN4 voltage dependence in sinoatrial myocytes.","method":"In vitro kinase assay; mass spectrometry; PKA inhibitor experiments on isolated SAN myocytes; truncation and alanine substitution mutagenesis; patch-clamp","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation with MS site identification plus mutagenesis and native cell electrophysiology; multiple orthogonal methods in single study","pmids":["20713547"],"is_preprint":false},{"year":2007,"finding":"Src tyrosine kinase forms a complex with HCN4 (co-immunoprecipitation in HEK293 cells and rat ventricular myocytes) and constitutively active Src shifts HCN4 activation to more positive voltages and accelerates kinetics, while dominant-negative Src has the opposite effect.","method":"Co-immunoprecipitation; co-transfection with constitutively active (Src529) or dominant-negative (Src296) Src in HEK293 cells; whole-cell patch-clamp","journal":"Journal of cardiovascular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP in two cell types plus functional gain/loss-of-function electrophysiology; single lab","pmids":["16680072"],"is_preprint":false},{"year":2007,"finding":"Src tyrosine kinase enhances HCN4 via Tyr531: mutation Y531F largely abolishes Src-mediated positive shift of voltage dependence and increased conductance, while Y554F selectively eliminates Src-induced kinetic changes without affecting voltage-dependent activation shift.","method":"Site-directed mutagenesis of HCN4; Src inhibitor PP2; whole-cell patch-clamp in HEK293 cells; heart rate measurement in mouse model","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis identifying specific phosphorylation sites combined with functional electrophysiology; single lab, two orthogonal approaches","pmids":["17977941"],"is_preprint":false},{"year":2003,"finding":"Specific residues in S1 (Leu272), the S1-S2 linker (Asn291, Thr293), and S2 (Ile308) of HCN4 determine its slower activation kinetics compared to HCN2; L272F in S1 accelerates HCN4 activation to match HCN2 speed, and I308M in S2 abolishes cAMP-dependent acceleration of activation.","method":"HCN2/4 chimeric channel analysis; site-directed mutagenesis; patch-clamp electrophysiology in heterologous expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution via chimeras and point mutagenesis with quantitative electrophysiology identifying specific residues; single lab, two orthogonal approaches","pmids":["12813043"],"is_preprint":false},{"year":2009,"finding":"MEF2 transcription factor directly binds an enhancer element (CNS13) in the Hcn4 genomic locus; dominant-negative MEF2 reduces Hcn4 mRNA expression and Ih current amplitude in embryonic heart inflow tract myocytes, establishing MEF2 as a direct transcriptional activator of Hcn4.","method":"Luciferase reporter assay; EMSA; chromatin immunoprecipitation (ChIP); dominant-negative MEF2 overexpression; patch-clamp of embryonic inflow-tract myocytes","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP, EMSA, and functional electrophysiology in native cells with dominant-negative perturbation; multiple orthogonal methods","pmids":["19477969"],"is_preprint":false},{"year":2006,"finding":"The NRSE motif in the HCN4 promoter binds NRSF (neuron-restrictive silencing factor); wild-type NRSE drives expression changes that match developmental and hypertrophic HCN4 expression patterns, whereas mutant NRSE constructs fail, implicating NRSF as a transcriptional repressor of HCN4.","method":"Promoter reporter assay in rat cardiac myocytes; NRSF binding confirmation; NRSE mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter assay with mutagenesis and protein-binding confirmation; single lab","pmids":["17173866"],"is_preprint":false},{"year":2008,"finding":"miR-1 directly targets the 3'-UTR of HCN4 to repress its protein expression; forced miR-1/miR-133 expression in hypertrophic cardiomyocytes prevents HCN4 overexpression, and downregulation of miR-1/miR-133 in hypertrophic hearts (linked to reduced serum-responsive factor) underlies pathological re-expression of HCN4.","method":"3'-UTR targeting confirmation; miRNA mimic transfection; miRNA-masking antisense; Western blot; patch-clamp; rat hypertrophy model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — miR-1 target validation with mimic and masking antisense, functional current measurement, in vivo hypertrophy model; replicated across multiple approaches and model systems","pmids":["18458081"],"is_preprint":false},{"year":2012,"finding":"HCN4 contains a conserved caveolin-binding domain (CBD) with aromatic residues Tyr259 and Phe262 at the N-terminus; disruption of CBD reduces HCN4-caveolin-1 interaction, causes cytoplasmic channel accumulation, and abolishes sensitivity to cholesterol depletion-induced caveolar disorganization, demonstrating that CBD mediates functional interaction with caveolin-1.","method":"CBD mutagenesis (Y259S, F262V, Y259F, F262Y); co-immunoprecipitation; whole-cell patch-clamp; confocal microscopy; cholesterol depletion in CHO cells","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis combined with co-IP, functional electrophysiology, and imaging; multiple orthogonal methods in single lab","pmids":["22659290"],"is_preprint":false},{"year":2012,"finding":"β2-adrenergic receptors form a protein complex with HCN4 via a proximal N-terminal region of HCN4; a synthetic peptide derived from this β2AR-binding domain disrupts the complex and prevents adrenergic augmentation of pacemaker currents and spontaneous contraction rates without affecting calcium current regulation.","method":"Co-immunoprecipitation; synthetic peptide disruption assay; patch-clamp; spontaneous contraction rate measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus peptide disruption functional assay; specific domain identified; single lab","pmids":["22613709"],"is_preprint":false},{"year":2009,"finding":"In adult mouse myocardium, HCN2 undergoes proteolytic cleavage to a ~60 kDa C-terminally truncated form lacking the cAMP-binding domain, which co-assembles with full-length HCN4 to form heteromeric channels; these heteromers activate faster than either homomer and resemble endogenous myocardial If, with HCN4 subunit supplying cAMP-mediated regulation.","method":"Western blot with N- and C-terminal-specific antibodies; co-immunoprecipitation of endogenous cardiac channels; heterologous co-expression; patch-clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — endogenous protein co-IP from mouse heart plus reconstitution of truncated HCN2+HCN4 heteromers with functional electrophysiology; multiple orthogonal methods","pmids":["19574228"],"is_preprint":false},{"year":2011,"finding":"The N-terminus of HCN4 exists as two tissue-specific isoforms (different transcription start sites), with only one present in brain and both in heart; the extended N-terminal isoform shifts activation to more negative voltages, and three positively charged residues (Arg9, Lys10, Lys22) in the N-terminus are responsible for this functional difference.","method":"RT-PCR of brain and heart mRNA; patch-clamp of HEK293 cells expressing each variant; site-directed mutagenesis of N-terminal charged residues","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis identifying specific residues with functional electrophysiology; two orthogonal methods; single lab","pmids":["21372143"],"is_preprint":false},{"year":2012,"finding":"The HCN4-K530N mutation in the C-linker alters heteromeric (but not homomeric) channel properties, producing a hyperpolarizing shift in half-maximal activation voltage; this is attributed to disruption of C-linker oligomerization equilibrium between tonically inhibited and activated tetrameric states.","method":"Patch-clamp of HEK293 cells expressing homomeric mutant and co-expression of mutant+WT (heteromeric); pedigree analysis","journal":"European heart journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — heteromeric vs homomeric functional comparison identifying C-linker mechanism; single lab electrophysiology","pmids":["23178648"],"is_preprint":false},{"year":2012,"finding":"cAMP-induced relief of HCN4 autoinhibition can occur in a cellular context- and isoform-specific manner without cAMP: HCN4 (but not HCN2) expressed in CHO (but not HEK) cells shows pre-relieved autoinhibition dependent on a ~300-aa distal C-terminal region (residues 719-1012), pointing to membrane-associated intracellular factors interacting with the distal C-terminus.","method":"Patch-clamp in CHO vs HEK cells; excised inside-out patches; domain truncation mutagenesis of HCN4 distal C-terminus; cAMP application","journal":"The Journal of general physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — domain-deletion mutagenesis with excised-patch controls; isoform comparison; single lab, multiple orthogonal methods","pmids":["23109717"],"is_preprint":false},{"year":2017,"finding":"miR-423-5p directly targets the 3'-UTR of HCN4 (luciferase reporter abolished by mutation of recognition elements); swim-training upregulates miR-423-5p and its host gene NSRP1 driven by Nkx2.5, repressing HCN4 and If in the sinus node; anti-miR-423-5p knockdown reverses training-induced bradycardia by rescuing HCN4 expression.","method":"3'-UTR luciferase reporter assay with recognition element mutation; next-generation miRNA sequencing; qRT-PCR; anti-miR knockdown in swim-trained mice; patch-clamp; chromatin immunoprecipitation for Nkx2.5","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — luciferase reporter with mutational validation, in vivo anti-miR rescue, patch-clamp, and ChIP; multiple orthogonal methods in single study","pmids":["28821541"],"is_preprint":false},{"year":2020,"finding":"A local circadian clock in the sinoatrial node drives day-night rhythms in Hcn4 expression via direct BMAL1 binding sites on the Hcn4 promoter (ChIP); cardiomyocyte-specific Bmal1 knockout abolishes day-night differences in Hcn4 mRNA and intrinsic heart rate; HCN block eliminates the day-night heart rate difference in vivo and in isolated SAN.","method":"Chromatin immunoprecipitation (ChIP) for BMAL1 at Hcn4 promoter; cardiomyocyte-specific Bmal1 KO mice; vagotomy; in vivo/in vitro ECG recording; HCN pharmacological block; reporter bioluminescence","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP linking transcription factor to Hcn4 promoter, transgenic KO with multiple phenotypic readouts, and pharmacological confirmation; multiple orthogonal methods","pmids":["33278629"],"is_preprint":false},{"year":2020,"finding":"LRMP and IRAG (homologous ER transmembrane proteins) associate with HCN4 and have opposing effects: LRMP inhibits cAMP-induced depolarizing shift in voltage dependence, while IRAG depolarizes basal voltage dependence in the absence of cAMP; both effects are isoform-specific to HCN4, independent of trafficking and cAMP binding, and IRAG is highly expressed in mouse sinoatrial node.","method":"Co-expression and functional patch-clamp in heterologous cells; co-immunoprecipitation; sinoatrial node expression analysis; computer modeling","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — co-IP plus patch-clamp with isoform-specificity controls and in vivo expression confirmation; multiple orthogonal methods in single study","pmids":["32647060"],"is_preprint":false},{"year":2021,"finding":"Shugoshin-1 (SGO1) directly interacts with HCN4 (co-immunoprecipitation) and promotes cell-surface expression and function of HCN4, enhancing funny current; the CAID syndrome mutation p.Lys23Glu in SGO1 impairs its interaction with HCN4, reduces membrane HCN4 expression, and depresses If in patient iPSC-derived cardiomyocytes.","method":"Co-immunoprecipitation; patch-clamp; surface expression assay; patient-specific iPSC-derived cardiomyocytes; neonatal rat ventricular myocyte model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — co-IP, functional electrophysiology, and disease-relevant iPSC model; multiple orthogonal methods in single study","pmids":["33953173"],"is_preprint":false},{"year":2024,"finding":"Cryo-EM structure of HCN4 in complex with ivabradine at 3 Å resolution shows ivabradine bound inside the open pore inner cavity; Y507 and I511 on S6 are the molecular determinants of ivabradine binding, F510 (pointing outside the pore) indirectly contributes by controlling Y507, and C479 in the selectivity filter accelerates block kinetics; molecular dynamics show ivabradine blocks a permeating ion via electrostatic repulsion.","method":"Cryo-EM structure at 3 Å; molecular dynamics simulations; functional validation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution cryo-EM structure of drug-channel complex with MD simulations defining binding mechanism; single study with strong structural evidence","pmids":["38917012"],"is_preprint":false},{"year":2009,"finding":"Sp1 transcription factor binds the core promoter regions of HCN4 and drives its transcription; siRNA knockdown of Sp1 prevents HCN4 overexpression in hypertrophic cardiomyocytes; Sp1 upregulation underlies pathological re-expression of HCN4 in ventricular hypertrophy.","method":"5'-RACE (transcription start site); luciferase reporter; siRNA knockdown of Sp1; Western blot; RT-PCR; rat hypertrophy model","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mapping plus siRNA perturbation and in vivo model; single lab, multiple methods","pmids":["19471099"],"is_preprint":false},{"year":2012,"finding":"Mef2c drives Hcn4 expression specifically in embryonic non-chamber and postnatal AV bundle myocardium through a conserved cis-regulatory element; HDAC inhibition expands this enhancer activity to working myocardium, and cardiac hypertrophy (causing nuclear HDAC export) ectopically activates the Hcn4 enhancer in working myocardium.","method":"Transgenic reporter mice; in vivo Mef2c-dependent enhancer analysis; HDAC inhibitor treatment; transverse aortic constriction hypertrophy model","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic reporter with Mef2c-dependence and HDAC manipulation; single lab","pmids":["23085412"],"is_preprint":false},{"year":2019,"finding":"Trx2 (mitochondrial thioredoxin-2) maintains HCN4 expression in the conduction system via a mitochondrial ROS–HDAC4–MEF2C pathway: Trx2 deletion elevates HDAC4, which binds the HCN4 enhancer via MEF2, reduces histone H3 acetylation at the MEF2 site, and decreases HCN4 transcription; mitochondria-specific ROS scavenger MitoTEMPO reverses HDAC4 elevation, HCN4 reduction, and sinus bradycardia.","method":"Conduction-system-specific Trx2 KO (Hcn4-CreERT2); ChIP; qPCR and Western blot for HCN4; MitoTEMPO rescue experiment; ECG telemetry","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — conduction-system-specific KO with ChIP mapping of HDAC4/MEF2 at HCN4 enhancer and pharmacological rescue; multiple orthogonal methods","pmids":["31751569"],"is_preprint":false},{"year":2013,"finding":"HCN4 co-localizes and co-immunoprecipitates with Thy1 in adult rat retinal ganglion cells, representing the first identified protein partner of HCN4 in the retina and showing that a GPI-anchored protein can complex with an HCN channel subunit.","method":"Co-immunoprecipitation with anti-Thy1 and anti-HCN4 antibodies; confocal immunohistochemistry; patch-clamp of immunopanned cells","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal co-IP from native tissue plus imaging and electrophysiology; single lab","pmids":["22281825"],"is_preprint":false},{"year":2018,"finding":"HCN4 pacemaker channels attenuate parasympathetic responses in the sinoatrial node: conditional knockdown of HCN4 enhances vagal bradycardia (complete sinus pause on vagus nerve stimulation), while HCN4 overexpression attenuates vagal bradycardia during β-adrenergic stimulation; neither manipulation significantly alters the β-adrenergic response alone.","method":"Tetracycline-inducible HCN4 overexpression and knockdown mouse lines; telemetric ECG; cervical vagus nerve stimulation; in vitro single pacemaker cell patch-clamp","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — gain- and loss-of-function in same inducible system with in vivo nerve stimulation and in vitro single-cell validation; multiple orthogonal methods","pmids":["29315578"],"is_preprint":false},{"year":2020,"finding":"Ectopic HCN4 expression in cortical neurons with mTOR hyperactivation drives epilepsy: HCN4 is expressed in focal cortical malformation (FCM) neurons in a TSC/FCDII mouse model, its expression is mTOR-dependent, increased intracellular cAMP preferentially drives repetitive firing via HCN4 in FCM neurons, and blocking HCN4 prevents seizures in the model.","method":"Mouse model of TSC/FCDII focal cortical malformation; pharmacological HCN4 block; cAMP manipulation; comparison of FCM vs. control pyramidal neurons; tissue from human TSC/FCDII patients (immunostaining)","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — loss-of-function pharmacological block prevents seizures, gain-of-function cAMP drives firing specifically via HCN4, mTOR-dependence established, human tissue confirmation; multiple orthogonal methods","pmids":["33208499"],"is_preprint":false},{"year":2013,"finding":"HCN4 and caveolin-3 (Cav3) co-localize in adult human atrial and ventricular cardiomyocytes but not in fetal cardiomyocytes; during hESC-CM maturation, Cav3 expression increases and HCN4-Cav3 co-localization develops by ~110 days, coinciding with a shift of f-current activation to more negative (adult-like) voltages; disruption of caveolae reverses voltage dependence toward a more positive (immature) phenotype in mature cells but not fetal cells.","method":"Immunocytochemistry; qRT-PCR; patch-clamp; methyl-β-cyclodextrin caveolae disruption in hESC-CMs at different maturation stages","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-localization with functional electrophysiology and pharmacological disruption across developmental stages; single lab","pmids":["23311301"],"is_preprint":false},{"year":2022,"finding":"Coxsackievirus B3 (CVB3) reduces HCN4 plasma membrane density in hiPSC-derived pacemaker-like cells by promoting autophagosomal HCN4 insertion via Rab7-dependent endocytic trafficking; individual CVB3 proteins 2C and 3A have the most potent effects on HCN4 activity, and pharmacological Rab7 inhibition or CVB3-3A inhibition (GW5074) rescues cytoplasmic HCN4 accumulation.","method":"hiPSC-derived pacemaker cells with inducible CVB3 expression; patch-clamp; immunofluorescence of HCN4 distribution; autophagosome assay; pharmacological rescue with Rab7 inhibitor and GW5074","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (Rab7/autophagosome) identified with pharmacological rescue; multiple methods; single lab","pmids":["35864219"],"is_preprint":false},{"year":2023,"finding":"A gain-of-function mutation p.V240M in the HCN domain (N-terminus) of HCN4 causes inappropriate sinus tachycardia by increasing single-channel conductance, opening frequency, and opening probability without altering cAMP sensitivity or membrane expression; the HCN domain therefore stabilizes the channel in the closed state.","method":"Macroscopic and single-channel patch-clamp in cells expressing WT and/or p.V240M HCN4; cell surface expression assay; computer simulation of sinoatrial node","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-channel recordings plus macroscopic current, surface expression, and computational modeling; multiple orthogonal methods in single study","pmids":["38032931"],"is_preprint":false},{"year":2023,"finding":"Molecular dynamics simulations of the HCN4 selectivity filter reveal two K+ binding sites and one Na+ binding site; Na+ acts as a weak blocker released by K+-induced filter widening, Li+ cannot enter the filter due to incomplete coordination, and Cs+ preferentially occupies the S3-equivalent site to block conduction, explaining weak cation selectivity.","method":"Molecular dynamics simulations of open HCN4 pore; comparison with experimental conductance data (Li+, Rb+, Cs+)","journal":"The Journal of general physiology","confidence":"Medium","confidence_rationale":"Tier 4 / Moderate — computational simulations recapitulating experimental ion selectivity data; no structural or mutagenesis validation in same paper","pmids":["37523352"],"is_preprint":false},{"year":2013,"finding":"Testosterone recruits the androgen receptor (AR) to regulatory regions of the HCN4 gene (confirmed by ChIP), associated with increased histone acetylation, upregulating HCN4 expression during cardiomyogenesis; AR knockdown or anti-androgenic treatment inhibits this effect.","method":"Chromatin immunoprecipitation (ChIP) for AR at HCN4 regulatory region; AR knockdown; histone acetylation analysis; RT-PCR and Western blot in mES and P19 cells","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identifying AR binding at HCN4 locus plus loss-of-function; single lab","pmids":["23598283"],"is_preprint":false},{"year":2020,"finding":"Notch1 signaling induces re-expression of HCN4 in mature cardiomyocytes via a regulatory complex of NICD and KDM5A (a histone demethylase) that targets the HCN4 promoter, promotes histone demethylation, and drives aconitine-induced ventricular arrhythmia; Notch1 inhibition reverses these changes.","method":"Co-immunoprecipitation of NICD-KDM5A complex; ChIP at HCN4 promoter; patch-clamp of beating rate; pharmacological Notch1 inhibitor rescue; human and rat cardiomyocytes","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of regulatory complex plus ChIP at HCN4 promoter with pharmacological rescue; single lab","pmids":["32234357"],"is_preprint":false},{"year":2021,"finding":"Cfp1 (CXXC finger protein 1) maintains HCN4 expression by binding the HCN4 promoter and maintaining H3K4 trimethylation, H3K9 acetylation, and H3K27 acetylation; Cfp1 heterozygous knockout reduces these histone marks, decreases HCN4 protein, and reduces If density by 66% in SAN cells, causing mild bradycardia.","method":"Cfp1 heterozygous KO mice (Hcn4-CreERT2 line); ChIP in HL-1 cells for H3K4me3, H3K9ac, H3K27ac at HCN4 promoter; patch-clamp; qPCR; Western blot","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP for multiple histone marks at HCN4 promoter plus patch-clamp and conduction-system-specific KO; multiple orthogonal methods","pmids":["34182171"],"is_preprint":false},{"year":2007,"finding":"The G480R mutation in the HCN4 pore domain causes familial sinus bradycardia through two mechanisms: reduced channel synthesis, a trafficking defect reducing plasma membrane expression (assessed by biotinylation/Western blot), and a shift of activation to more negative voltages.","method":"Sequencing; expression in Xenopus oocytes and HEK293 cells; patch-clamp; surface biotinylation; Western blot","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple complementary functional assays plus surface expression quantification; single lab","pmids":["17646576"],"is_preprint":false},{"year":2020,"finding":"HCN4-expressing enteric neurons in zebrafish specifically regulate retrograde (but not anterograde) peristalsis: HCN channel block or morpholino knockdown selectively attenuates retrograde peristalsis, while optogenetic activation of HCN4+ neurons (channelrhodopsin) selectively enhances retrograde peristalsis.","method":"Forward genetics in zebrafish; HCN channel pharmacological block; morpholino knockdown; optogenetic activation of HCN4+ neurons expressing channelrhodopsin; peristalsis measurement","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — forward genetics discovery plus orthogonal loss- and gain-of-function (pharmacology, morpholino, optogenetics) with specific functional readout","pmids":["32130893"],"is_preprint":false}],"current_model":"HCN4 is the principal pore-forming subunit of the cardiac 'funny' (If) pacemaker current, a hyperpolarization-activated, cAMP-regulated cation channel whose gating is governed by its CNBD/C-linker (crystal structure solved), N-terminal HCN domain, and S1-S2-S6 transmembrane segments; it is activated at diastolic membrane potentials, modulated by direct cAMP binding (relieving C-linker autoinhibition), PKA phosphorylation at multiple C-terminal sites, Src tyrosine kinase (via Tyr531), caveolin-1 (via an N-terminal CBD), KCNE2 and LRMP/IRAG auxiliary subunits, and β2-adrenergic receptor co-complexes, while its transcription is controlled by MEF2C/HDAC, NRSF, Sp1, BMAL1 (circadian clock), and post-transcriptionally by miR-1 and miR-423-5p; cardiac-specific knockout in adult mice produces severe bradycardia and AV block, establishing its essential role in sinoatrial pacemaking, and ectopic HCN4 expression in mTOR-activated cortical neurons drives epilepsy via a cAMP-dependent mechanism."},"narrative":{"mechanistic_narrative":"HCN4 is the principal pore-forming subunit of the cardiac hyperpolarization-activated 'funny' (If) pacemaker current, and its activity is essential for sinoatrial impulse generation and conduction: inducible cardiac-specific knockout in adult mice produces severe bradycardia, AV block, and death with profound loss of SAN If current [PMID:21220308]. The channel is a weakly selective cation conductance whose gating is set by defined structural modules — N-terminal HCN domain residues that stabilize the closed state (a gain-of-function p.V240M mutation increases open probability and conductance to cause inappropriate sinus tachycardia) [PMID:38032931], S1/S1-S2/S2 residues that tune activation kinetics relative to HCN2 [PMID:12813043], and a C-linker/CNBD whose crystal structure explains HCN4's attenuated cAMP response relative to HCN2 [PMID:20829353], with cAMP binding relieving C-linker autoinhibition in an isoform- and context-dependent manner [PMID:23109717]. cAMP-dependent regulation underlies its physiological roles in autonomic heart-rate control, where HCN4 attenuates parasympathetic (vagal) bradycardia [PMID:29315578], and in disease, where ectopic HCN4 in mTOR-hyperactivated cortical neurons drives cAMP-dependent repetitive firing and seizures [PMID:33208499]. Channel function is shaped by an array of direct partners and modulators: PKA phosphorylates HCN4 at multiple C-terminal sites to shift voltage dependence [PMID:20713547], Src tyrosine kinase enhances the current via Tyr531 [PMID:16680072, PMID:17977941], the auxiliary subunit KCNE2 [PMID:12856183] and the ER proteins LRMP and IRAG exert opposing isoform-specific effects on cAMP-dependent gating [PMID:32647060], caveolin-1 binding through an N-terminal CBD controls localization [PMID:22659290], and β2-adrenergic receptors form an N-terminal co-complex required for adrenergic augmentation of pacemaking [PMID:22613709]. Trafficking and surface density are governed by SGO1, whose CAID-syndrome mutation impairs HCN4 membrane expression [PMID:33953173], and are disrupted by trafficking-defective disease mutations (D553N, G480R) [PMID:15123648, PMID:17646576] and by coxsackievirus-driven Rab7-dependent internalization [PMID:35864219]. HCN4 transcription is tightly controlled by MEF2C acting through a conserved enhancer (modulated by HDAC export and a mitochondrial Trx2–ROS–HDAC4 axis) [PMID:19477969, PMID:23085412, PMID:31751569], by Sp1 [PMID:19471099], NRSF [PMID:17173866], the circadian factor BMAL1 driving day-night heart-rate rhythms [PMID:33278629], and chromatin regulators including Cfp1 [PMID:34182171], while miR-1 and miR-423-5p repress it post-transcriptionally during hypertrophy and exercise training [PMID:18458081, PMID:28821541]. The channel is also the molecular target of the bradycardic drug ivabradine, which binds the open-pore inner cavity via S6 residues Y507 and I511 [PMID:38917012].","teleology":[{"year":2001,"claim":"Establishing that HCN4 channels could be gated by extracellular protons defined a sensory-transduction role beyond simple voltage-dependent pacemaking.","evidence":"In situ hybridization and patch-clamp of native taste cells plus heterologous HCN expression","pmids":["11675786"],"confidence":"High","gaps":["Did not establish the cardiac pacemaker role","Molecular site of proton gating not mapped"]},{"year":2003,"claim":"Chimera and mutagenesis work answered which residues set HCN4's characteristically slow activation, mapping kinetic determinants to S1, the S1-S2 linker, and S2.","evidence":"HCN2/4 chimeras and point mutagenesis with patch-clamp in heterologous cells","pmids":["12813043"],"confidence":"High","gaps":["Structural basis not resolved","Did not address native heteromeric channels"]},{"year":2003,"claim":"Co-assembly studies addressed the subunit composition of native f-channels, showing HCN4-HCN1 heteromers and KCNE2 association reshape gating toward native SAN If.","evidence":"Tandem-construct and co-expression patch-clamp plus yeast two-hybrid for KCNE2","pmids":["12702747","12856183"],"confidence":"Medium","gaps":["cAMP sensitivity of heteromers did not fully match native current","Stoichiometry in vivo unresolved","KCNE2 interaction shown only by Y2H, not in native tissue"]},{"year":2004,"claim":"The first disease mutation (D553N) defined trafficking impairment as a dominant-negative loss-of-function mechanism for sinus node dysfunction.","evidence":"HEK293 expression with patch-clamp, surface biotinylation, and Western blot","pmids":["15123648"],"confidence":"Medium","gaps":["Single lab","Trafficking machinery involved not identified"]},{"year":2009,"claim":"Endogenous co-IP from heart resolved how native myocardial If arises, showing a cleaved cAMP-insensitive HCN2 fragment heteromerizes with full-length HCN4.","evidence":"Antibody-specific Western blot, co-IP of cardiac channels, and reconstitution patch-clamp","pmids":["19574228"],"confidence":"High","gaps":["Protease responsible for HCN2 cleavage unknown","Physiological relevance of heteromers in pacemaking not quantified"]},{"year":2010,"claim":"Structural and biochemical work defined cAMP regulation, with the C-linker/CNBD crystal structure explaining HCN4's reduced cAMP response and mass spectrometry mapping PKA phosphorylation sites controlling voltage dependence.","evidence":"2.4 Å X-ray crystallography with mutagenesis, plus in vitro kinase/MS and SAN myocyte patch-clamp","pmids":["20829353","20713547"],"confidence":"High","gaps":["Full-length channel structure absent","How distinct PKA sites integrate not resolved"]},{"year":2012,"claim":"Identification of N-terminal partner domains established how HCN4 is localized and adrenergically tuned, via a caveolin-1-binding CBD and a β2AR co-complex domain.","evidence":"Mutagenesis, co-IP, peptide disruption, patch-clamp, and confocal imaging","pmids":["22659290","22613709"],"confidence":"Medium","gaps":["Single lab for each interaction","Structural detail of complexes lacking"]},{"year":2012,"claim":"Studies of N-terminal isoforms, a C-linker disease mutation, and context-dependent autoinhibition relief defined how intracellular regions modulate basal and cAMP-dependent gating.","evidence":"RT-PCR isoform mapping, mutagenesis, and excised-patch electrophysiology in CHO vs HEK cells","pmids":["21372143","23178648","23109717"],"confidence":"Medium","gaps":["The membrane-associated factor relieving autoinhibition in CHO cells unidentified","K530N heteromeric mechanism inferred indirectly"]},{"year":2007,"claim":"Src kinase was established as a direct positive modulator, with Tyr531 and Tyr554 dissecting voltage-shift versus kinetic effects.","evidence":"Co-IP in two cell types, constitutively active/dominant-negative Src, site-directed mutagenesis, and patch-clamp","pmids":["16680072","17977941"],"confidence":"Medium","gaps":["Single lab","In vivo relevance of Src tyrosine phosphorylation not fully established"]},{"year":2009,"claim":"Transcriptional control was defined through MEF2 binding a conserved Hcn4 enhancer and Sp1 driving the core promoter, including pathological re-expression in hypertrophy.","evidence":"ChIP, EMSA, luciferase reporters, dominant-negative MEF2, Sp1 siRNA, and patch-clamp","pmids":["19477969","19471099"],"confidence":"Medium","gaps":["Combinatorial control with other factors unresolved","Direct MEF2 vs Sp1 hierarchy not established"]},{"year":2008,"claim":"Post-transcriptional repression by miR-1 was established as a mechanism preventing pathological HCN4 overexpression in hypertrophy.","evidence":"3'-UTR targeting, mimic and masking antisense, Western blot, patch-clamp, and rat hypertrophy model","pmids":["18458081"],"confidence":"High","gaps":["Relative contribution vs transcriptional control unclear"]},{"year":2011,"claim":"Cardiac-specific inducible knockout definitively established HCN4 as essential for adult cardiac impulse generation and conduction.","evidence":"Inducible cardiac Cre-lox KO with SAN patch-clamp, immunofluorescence, and telemetric ECG","pmids":["21220308"],"confidence":"High","gaps":["Did not dissect SAN vs AV-node contributions mechanistically"]},{"year":2018,"claim":"Gain- and loss-of-function in the same inducible system revealed that HCN4 buffers parasympathetic (vagal) bradycardia in the SAN.","evidence":"Tetracycline-inducible HCN4 overexpression/knockdown mice with in vivo vagal stimulation and single-cell patch-clamp","pmids":["29315578"],"confidence":"High","gaps":["Molecular link between If and cholinergic signaling not defined"]},{"year":2020,"claim":"Auxiliary ER proteins LRMP and IRAG were identified as isoform-specific, oppositely-acting modulators of HCN4 cAMP-dependent gating, with IRAG enriched in SAN.","evidence":"Co-expression patch-clamp, co-IP, SAN expression analysis, and modeling","pmids":["32647060"],"confidence":"High","gaps":["Structural basis of opposing effects unknown","Physiological IRAG/LRMP balance in vivo not measured"]},{"year":2020,"claim":"Circadian and metabolic transcriptional axes were established: BMAL1 directly drives day-night Hcn4 rhythms and a mitochondrial Trx2-ROS-HDAC4-MEF2C pathway maintains conduction-system HCN4.","evidence":"ChIP, cardiomyocyte/conduction-system-specific KO mice, pharmacological rescue (MitoTEMPO, HCN block), and ECG","pmids":["33278629","31751569"],"confidence":"High","gaps":["Interplay between circadian and ROS-driven control not integrated","Upstream signals coupling metabolism to HDAC4 incompletely mapped"]},{"year":2020,"claim":"Ectopic HCN4 was shown to be pathogenic outside the heart, driving cAMP-dependent epileptic firing in mTOR-hyperactivated cortical neurons.","evidence":"TSC/FCDII mouse model, pharmacological HCN4 block, cAMP manipulation, and human tissue immunostaining","pmids":["33208499"],"confidence":"High","gaps":["Transcriptional mechanism of mTOR-driven HCN4 induction not fully defined"]},{"year":2021,"claim":"Trafficking partners and chromatin regulators were identified: SGO1 promotes HCN4 surface expression (disrupted in CAID syndrome) and Cfp1 maintains activating histone marks at the HCN4 promoter.","evidence":"Co-IP, surface assays, patient iPSC-CMs, ChIP for histone marks, and patch-clamp in conduction-system-specific KO","pmids":["33953173","34182171"],"confidence":"High","gaps":["Mechanism of SGO1-mediated surface delivery not resolved","Direct vs indirect Cfp1 effects on HCN4 not separated"]},{"year":2023,"claim":"Single-channel analysis of a gain-of-function HCN-domain mutation (p.V240M) established that the N-terminal HCN domain stabilizes the closed state, linking inappropriate sinus tachycardia to increased open probability.","evidence":"Macroscopic and single-channel patch-clamp, surface expression assay, and SAN computer modeling","pmids":["38032931"],"confidence":"High","gaps":["Structural mechanism of HCN-domain closed-state stabilization not visualized"]},{"year":2024,"claim":"Atomic-resolution structure defined the pharmacological target site, showing ivabradine blocks the open-pore inner cavity via S6 residues Y507 and I511.","evidence":"3 Å cryo-EM of the HCN4-ivabradine complex with molecular dynamics and functional validation","pmids":["38917012"],"confidence":"High","gaps":["Full gating-cycle structures still lacking","Ion-selectivity mechanism addressed only computationally [#33]"]},{"year":null,"claim":"How the many transcriptional, post-transcriptional, phosphorylation, trafficking, and auxiliary-subunit inputs are integrated to set beat-to-beat If in vivo, and the full-length channel gating-cycle structure, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length apo/cAMP-bound HCN4 structure across gating states","Quantitative hierarchy of regulators in native SAN unknown","Ion selectivity mechanism not experimentally validated by structure/mutagenesis"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,9,33]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[5,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,13,22,37]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13,31]}],"pathway":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10,24,20,25]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[0,28]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,14,18]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[20]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[29,38]}],"complexes":["HCN4-HCN1 heteromeric channel","HCN4-cleaved HCN2 heteromeric channel","HCN4-β2AR co-complex"],"partners":["KCNE2","SRC","CAV1","ADRB2","LRMP","IRAG","SGO1","THY1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y3Q4","full_name":"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","aliases":[],"length_aa":1203,"mass_kda":129.0,"function":"Hyperpolarization-activated ion channel that are permeable to Na(+) and K(+) ions with very slow activation and inactivation (PubMed:10228147, PubMed:10430953, PubMed:20829353). Exhibits higher selectivity for K(+) over Na(+) ions (PubMed:10228147). Contributes to the native pacemaker currents in heart (If) that regulate the rhythm of heart beat (Probable) (PubMed:10228147, PubMed:16407510, PubMed:19165230). Contributes to the native pacemaker currents in neurons (Ih) (Probable). May mediate responses to sour stimuli (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9Y3Q4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HCN4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HCN4","total_profiled":1310},"omim":[{"mim_id":"619521","title":"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18; EIG18","url":"https://www.omim.org/entry/619521"},{"mim_id":"613123","title":"BRUGADA SYNDROME 8; BRGDA8","url":"https://www.omim.org/entry/613123"},{"mim_id":"608567","title":"SICK SINUS SYNDROME 1; SSS1","url":"https://www.omim.org/entry/608567"},{"mim_id":"605206","title":"HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4","url":"https://www.omim.org/entry/605206"},{"mim_id":"602780","title":"HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1","url":"https://www.omim.org/entry/602780"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"heart muscle","ntpm":8.2},{"tissue":"testis","ntpm":7.0}],"url":"https://www.proteinatlas.org/search/HCN4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9Y3Q4","domains":[{"cath_id":"-","chopping":"213-409","consensus_level":"medium","plddt":86.0334,"start":213,"end":409},{"cath_id":"1.10.287,1.10.287","chopping":"410-521","consensus_level":"medium","plddt":92.1818,"start":410,"end":521},{"cath_id":"2.60.120.10","chopping":"587-763","consensus_level":"high","plddt":86.6703,"start":587,"end":763}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y3Q4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y3Q4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y3Q4-F1-predicted_aligned_error_v6.png","plddt_mean":59.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HCN4","jax_strain_url":"https://www.jax.org/strain/search?query=HCN4"},"sequence":{"accession":"Q9Y3Q4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y3Q4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y3Q4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y3Q4"}},"corpus_meta":[{"pmid":"21220308","id":"PMC_21220308","title":"Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21220308","citation_count":230,"is_preprint":false},{"pmid":"23743334","id":"PMC_23743334","title":"HCN4 dynamically marks the first heart field and conduction system precursors.","date":"2013","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/23743334","citation_count":181,"is_preprint":false},{"pmid":"12702747","id":"PMC_12702747","title":"Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node.","date":"2003","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12702747","citation_count":179,"is_preprint":false},{"pmid":"11675786","id":"PMC_11675786","title":"Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli.","date":"2001","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11675786","citation_count":173,"is_preprint":false},{"pmid":"15123648","id":"PMC_15123648","title":"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15123648","citation_count":162,"is_preprint":false},{"pmid":"17516552","id":"PMC_17516552","title":"Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17516552","citation_count":149,"is_preprint":false},{"pmid":"25145517","id":"PMC_25145517","title":"HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy.","date":"2014","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25145517","citation_count":148,"is_preprint":false},{"pmid":"23974038","id":"PMC_23974038","title":"A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.","date":"2013","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23974038","citation_count":148,"is_preprint":false},{"pmid":"18458081","id":"PMC_18458081","title":"Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18458081","citation_count":147,"is_preprint":false},{"pmid":"17646576","id":"PMC_17646576","title":"Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.","date":"2007","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/17646576","citation_count":120,"is_preprint":false},{"pmid":"25145518","id":"PMC_25145518","title":"The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel.","date":"2014","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25145518","citation_count":113,"is_preprint":false},{"pmid":"16989793","id":"PMC_16989793","title":"Extended atrial conduction system characterised by the expression of the HCN4 channel and connexin45.","date":"2006","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/16989793","citation_count":91,"is_preprint":false},{"pmid":"14643687","id":"PMC_14643687","title":"Expression of the hyperpolarization-activated cyclic nucleotide-gated cation channel HCN4 during mouse heart development.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/14643687","citation_count":89,"is_preprint":false},{"pmid":"12856183","id":"PMC_12856183","title":"KCNE2 modulates current amplitudes and activation kinetics of HCN4: influence of KCNE family members on HCN4 currents.","date":"2003","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12856183","citation_count":85,"is_preprint":false},{"pmid":"25642760","id":"PMC_25642760","title":"Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25642760","citation_count":83,"is_preprint":false},{"pmid":"20829353","id":"PMC_20829353","title":"Structural basis for the cAMP-dependent gating in the human HCN4 channel.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20829353","citation_count":82,"is_preprint":false},{"pmid":"20713547","id":"PMC_20713547","title":"Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.","date":"2010","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20713547","citation_count":81,"is_preprint":false},{"pmid":"23178648","id":"PMC_23178648","title":"Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation.","date":"2012","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/23178648","citation_count":76,"is_preprint":false},{"pmid":"28821541","id":"PMC_28821541","title":"Targeting miR-423-5p Reverses Exercise Training-Induced HCN4 Channel Remodeling and Sinus Bradycardia.","date":"2017","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28821541","citation_count":73,"is_preprint":false},{"pmid":"19165230","id":"PMC_19165230","title":"Role of HCN4 channel in preventing ventricular arrhythmia.","date":"2009","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19165230","citation_count":67,"is_preprint":false},{"pmid":"19394343","id":"PMC_19394343","title":"Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19394343","citation_count":66,"is_preprint":false},{"pmid":"33278629","id":"PMC_33278629","title":"A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate.","date":"2020","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/33278629","citation_count":65,"is_preprint":false},{"pmid":"25986146","id":"PMC_25986146","title":"Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4.","date":"2015","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25986146","citation_count":57,"is_preprint":false},{"pmid":"24607718","id":"PMC_24607718","title":"A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation.","date":"2014","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/24607718","citation_count":55,"is_preprint":false},{"pmid":"20662977","id":"PMC_20662977","title":"A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews.","date":"2010","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/20662977","citation_count":53,"is_preprint":false},{"pmid":"22659290","id":"PMC_22659290","title":"A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins.","date":"2012","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/22659290","citation_count":50,"is_preprint":false},{"pmid":"12813043","id":"PMC_12813043","title":"Molecular basis for the different activation kinetics of the pacemaker channels HCN2 and HCN4.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12813043","citation_count":48,"is_preprint":false},{"pmid":"23357121","id":"PMC_23357121","title":"HCN4 subunit expression in fast-spiking interneurons of the rat spinal cord and hippocampus.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23357121","citation_count":47,"is_preprint":false},{"pmid":"26835093","id":"PMC_26835093","title":"HCN4, Sinus Bradycardia and Atrial Fibrillation.","date":"2015","source":"Arrhythmia & electrophysiology review","url":"https://pubmed.ncbi.nlm.nih.gov/26835093","citation_count":46,"is_preprint":false},{"pmid":"33208499","id":"PMC_33208499","title":"Ectopic HCN4 expression drives mTOR-dependent epilepsy in mice.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33208499","citation_count":44,"is_preprint":false},{"pmid":"17977941","id":"PMC_17977941","title":"Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17977941","citation_count":39,"is_preprint":false},{"pmid":"21421080","id":"PMC_21421080","title":"Funny current channel HCN4 delineates the developing cardiac conduction system in chicken heart.","date":"2011","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/21421080","citation_count":38,"is_preprint":false},{"pmid":"24569893","id":"PMC_24569893","title":"Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current.","date":"2014","source":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24569893","citation_count":37,"is_preprint":false},{"pmid":"28104484","id":"PMC_28104484","title":"Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction.","date":"2017","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/28104484","citation_count":37,"is_preprint":false},{"pmid":"16680072","id":"PMC_16680072","title":"Constitutively active Src tyrosine kinase changes gating of HCN4 channels through direct binding to the channel proteins.","date":"2006","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16680072","citation_count":37,"is_preprint":false},{"pmid":"19477969","id":"PMC_19477969","title":"The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2.","date":"2009","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/19477969","citation_count":36,"is_preprint":false},{"pmid":"17173866","id":"PMC_17173866","title":"NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17173866","citation_count":35,"is_preprint":false},{"pmid":"26384234","id":"PMC_26384234","title":"Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26384234","citation_count":35,"is_preprint":false},{"pmid":"23311301","id":"PMC_23311301","title":"Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.","date":"2013","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/23311301","citation_count":34,"is_preprint":false},{"pmid":"30127718","id":"PMC_30127718","title":"A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30127718","citation_count":32,"is_preprint":false},{"pmid":"29315578","id":"PMC_29315578","title":"HCN4 pacemaker channels attenuate the parasympathetic response and stabilize the spontaneous firing of the sinoatrial node.","date":"2018","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29315578","citation_count":31,"is_preprint":false},{"pmid":"28871229","id":"PMC_28871229","title":"Gabapentin Modulates HCN4 Channel Voltage-Dependence.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28871229","citation_count":28,"is_preprint":false},{"pmid":"17382969","id":"PMC_17382969","title":"Adenoviral gene transfer of HCN4 creates a genetic pacemaker in pigs with complete atrioventricular block.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17382969","citation_count":28,"is_preprint":false},{"pmid":"18383475","id":"PMC_18383475","title":"Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer.","date":"2008","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18383475","citation_count":28,"is_preprint":false},{"pmid":"23085412","id":"PMC_23085412","title":"Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23085412","citation_count":27,"is_preprint":false},{"pmid":"25442735","id":"PMC_25442735","title":"Insights into cardiac conduction system formation provided by HCN4 expression.","date":"2014","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25442735","citation_count":25,"is_preprint":false},{"pmid":"29588962","id":"PMC_29588962","title":"Functional variants in HCN4 and CACNA1H may contribute to genetic generalized epilepsy.","date":"2017","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/29588962","citation_count":25,"is_preprint":false},{"pmid":"20381460","id":"PMC_20381460","title":"Dynamic changes in HCN2, HCN4, KCNE1, and KCNE2 expression in ventricular cells from acute myocardial infarction rat hearts.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20381460","citation_count":25,"is_preprint":false},{"pmid":"27553229","id":"PMC_27553229","title":"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.","date":"2016","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27553229","citation_count":24,"is_preprint":false},{"pmid":"19820968","id":"PMC_19820968","title":"Hyperpolarization-activated cyclic-nucleotide gated 4 (HCN4) protein is expressed in a subset of rat dorsal root and trigeminal ganglion neurons.","date":"2009","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/19820968","citation_count":24,"is_preprint":false},{"pmid":"30585408","id":"PMC_30585408","title":"HCN4 knockdown in dorsal hippocampus promotes anxiety-like behavior in mice.","date":"2019","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/30585408","citation_count":23,"is_preprint":false},{"pmid":"23598283","id":"PMC_23598283","title":"Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes.","date":"2013","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23598283","citation_count":22,"is_preprint":false},{"pmid":"20179882","id":"PMC_20179882","title":"Hysteresis in human HCN4 channels: a crucial feature potentially affecting sinoatrial node pacemaking.","date":"2010","source":"Sheng li xue bao : [Acta physiologica Sinica]","url":"https://pubmed.ncbi.nlm.nih.gov/20179882","citation_count":22,"is_preprint":false},{"pmid":"32647060","id":"PMC_32647060","title":"Isoform-specific regulation of HCN4 channels by a family of endoplasmic reticulum proteins.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32647060","citation_count":21,"is_preprint":false},{"pmid":"19574228","id":"PMC_19574228","title":"Proteolytic processing of HCN2 and co-assembly with HCN4 in the generation of cardiac pacemaker channels.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19574228","citation_count":21,"is_preprint":false},{"pmid":"19471099","id":"PMC_19471099","title":"Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes.","date":"2009","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19471099","citation_count":21,"is_preprint":false},{"pmid":"23109717","id":"PMC_23109717","title":"Cellular context and multiple channel domains determine cAMP sensitivity of HCN4 channels: ligand-independent relief of autoinhibition in HCN4.","date":"2012","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23109717","citation_count":20,"is_preprint":false},{"pmid":"24492017","id":"PMC_24492017","title":"A novel HCN4 mutation, G1097W, is associated with atrioventricular block.","date":"2014","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/24492017","citation_count":20,"is_preprint":false},{"pmid":"21529705","id":"PMC_21529705","title":"Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21529705","citation_count":20,"is_preprint":false},{"pmid":"38032931","id":"PMC_38032931","title":"A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38032931","citation_count":18,"is_preprint":false},{"pmid":"22613709","id":"PMC_22613709","title":"Adrenergic regulation of HCN4 channel requires protein association with β2-adrenergic receptor.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22613709","citation_count":18,"is_preprint":false},{"pmid":"31555092","id":"PMC_31555092","title":"Using a Multiplex Nucleic Acid in situ Hybridization Technique to Determine HCN4 mRNA Expression in the Adult Rodent Brain.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31555092","citation_count":18,"is_preprint":false},{"pmid":"31751569","id":"PMC_31751569","title":"Mitochondrial thioredoxin-2 maintains HCN4 expression and prevents oxidative stress-mediated sick sinus syndrome.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/31751569","citation_count":17,"is_preprint":false},{"pmid":"35556164","id":"PMC_35556164","title":"Paradigm shift: new concepts for HCN4 function in cardiac pacemaking.","date":"2022","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35556164","citation_count":17,"is_preprint":false},{"pmid":"19895411","id":"PMC_19895411","title":"Identification, isolation and characterization of HCN4-positive pacemaking cells derived from murine embryonic stem cells during cardiac differentiation.","date":"2009","source":"Pacing and clinical electrophysiology : PACE","url":"https://pubmed.ncbi.nlm.nih.gov/19895411","citation_count":17,"is_preprint":false},{"pmid":"32130893","id":"PMC_32130893","title":"Gastrointestinal Neurons Expressing HCN4 Regulate Retrograde Peristalsis.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32130893","citation_count":16,"is_preprint":false},{"pmid":"26206080","id":"PMC_26206080","title":"HCN4 mutation as a molecular explanation on patients with bradycardia and non-compaction cardiomyopathy.","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26206080","citation_count":16,"is_preprint":false},{"pmid":"35328031","id":"PMC_35328031","title":"Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328031","citation_count":15,"is_preprint":false},{"pmid":"29349559","id":"PMC_29349559","title":"A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction.","date":"2018","source":"Heart and vessels","url":"https://pubmed.ncbi.nlm.nih.gov/29349559","citation_count":15,"is_preprint":false},{"pmid":"29987112","id":"PMC_29987112","title":"HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycardia-Induced Cardiomyopathy in Patients With Atrial Fibrillation.","date":"2018","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29987112","citation_count":14,"is_preprint":false},{"pmid":"33953173","id":"PMC_33953173","title":"Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33953173","citation_count":14,"is_preprint":false},{"pmid":"31481236","id":"PMC_31481236","title":"The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31481236","citation_count":14,"is_preprint":false},{"pmid":"30196304","id":"PMC_30196304","title":"In Vitro Analyses of Novel HCN4 Gene Mutations.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30196304","citation_count":13,"is_preprint":false},{"pmid":"22683190","id":"PMC_22683190","title":"Hyperpolarisation-activated cyclic nucleotide channel 4 (HCN4) involvement in Tourette's syndrome autoimmunity.","date":"2012","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/22683190","citation_count":13,"is_preprint":false},{"pmid":"23768927","id":"PMC_23768927","title":"In situ investigation of allografted mouse HCN4 gene-transfected rat bone marrow mesenchymal stromal cells with the use of patch-clamp recording of ventricular slices.","date":"2013","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/23768927","citation_count":13,"is_preprint":false},{"pmid":"38917012","id":"PMC_38917012","title":"Structural determinants of ivabradine block of the open pore of HCN4.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38917012","citation_count":12,"is_preprint":false},{"pmid":"28465117","id":"PMC_28465117","title":"A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability.","date":"2017","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28465117","citation_count":12,"is_preprint":false},{"pmid":"24281837","id":"PMC_24281837","title":"Inducible gene deletion in the entire cardiac conduction system using Hcn4-CreERT2 BAC transgenic mice.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24281837","citation_count":12,"is_preprint":false},{"pmid":"32234357","id":"PMC_32234357","title":"Notch1-mediated histone demethylation of HCN4 contributes to aconitine-induced ventricular myocardial dysrhythmia.","date":"2020","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32234357","citation_count":11,"is_preprint":false},{"pmid":"29628472","id":"PMC_29628472","title":"HCN4-Overexpressing Mouse Embryonic Stem Cell-Derived Cardiomyocytes Generate a New Rapid Rhythm in Rats with Bradycardia.","date":"2018","source":"International heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/29628472","citation_count":11,"is_preprint":false},{"pmid":"31291594","id":"PMC_31291594","title":"Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31291594","citation_count":10,"is_preprint":false},{"pmid":"35864219","id":"PMC_35864219","title":"Virus-induced inhibition of cardiac pacemaker channel HCN4 triggers bradycardia in human-induced stem cell system.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35864219","citation_count":10,"is_preprint":false},{"pmid":"34215719","id":"PMC_34215719","title":"Downregulated lncRNA RCPCD promotes differentiation of embryonic stem cells into cardiac pacemaker-like cells by suppressing HCN4 promoter methylation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34215719","citation_count":10,"is_preprint":false},{"pmid":"22281825","id":"PMC_22281825","title":"Thy1 associates with the cation channel subunit HCN4 in adult rat retina.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22281825","citation_count":10,"is_preprint":false},{"pmid":"18282314","id":"PMC_18282314","title":"HCN4-like immunoreactivity in rat retinal ganglion cells.","date":"2008","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18282314","citation_count":10,"is_preprint":false},{"pmid":"30794847","id":"PMC_30794847","title":"Protein and surface expression of HCN2 and HCN4 subunits in mesocorticolimbic areas after cocaine sensitization.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/30794847","citation_count":9,"is_preprint":false},{"pmid":"21372143","id":"PMC_21372143","title":"Tissue-specific N terminus of the HCN4 channel affects channel activation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21372143","citation_count":9,"is_preprint":false},{"pmid":"20207172","id":"PMC_20207172","title":"Expression of hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN4) is increased in hypertrophic cardiomyopathy.","date":"2010","source":"Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20207172","citation_count":9,"is_preprint":false},{"pmid":"37523352","id":"PMC_37523352","title":"Alkali metal cations modulate the geometry of different binding sites in HCN4 selectivity filter for permeation or block.","date":"2023","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37523352","citation_count":9,"is_preprint":false},{"pmid":"22107837","id":"PMC_22107837","title":"Blocking effects of acehytisine on pacemaker currents (I(f)) in sinoatrial node cells and human HCN4 channels expressed in Xenopus laevis oocytes.","date":"2011","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22107837","citation_count":9,"is_preprint":false},{"pmid":"35365232","id":"PMC_35365232","title":"Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35365232","citation_count":8,"is_preprint":false},{"pmid":"23075627","id":"PMC_23075627","title":"The HCN4 channel mutation D553N associated with bradycardia has a C-linker mediated gating defect.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23075627","citation_count":8,"is_preprint":false},{"pmid":"33450487","id":"PMC_33450487","title":"Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.","date":"2021","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33450487","citation_count":8,"is_preprint":false},{"pmid":"26550270","id":"PMC_26550270","title":"Morphology of mouse sinoatrial node and its expression of NF-160 and HCN4.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26550270","citation_count":7,"is_preprint":false},{"pmid":"37879946","id":"PMC_37879946","title":"Electroacupuncture inhibits PDK1/Akt/HCN4 pathway to improve neurogenic urinary retention in rats.","date":"2023","source":"Zhen ci yan jiu = Acupuncture research","url":"https://pubmed.ncbi.nlm.nih.gov/37879946","citation_count":6,"is_preprint":false},{"pmid":"31315459","id":"PMC_31315459","title":"Correlation between HCN4 gene polymorphisms and lone atrial fibrillation risk.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31315459","citation_count":5,"is_preprint":false},{"pmid":"32948209","id":"PMC_32948209","title":"Expression of the pacemaker channel HCN4 in excitatory interneurons in the dorsal horn of the murine spinal cord.","date":"2020","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/32948209","citation_count":5,"is_preprint":false},{"pmid":"33095298","id":"PMC_33095298","title":"Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.","date":"2020","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33095298","citation_count":5,"is_preprint":false},{"pmid":"34182171","id":"PMC_34182171","title":"Deficiency of CXXC finger protein 1 leads to small changes in heart rate but moderate epigenetic alterations and significant protein downregulation of hyperpolarization-activated cyclic nucleotide-gated 4 (HCN4) ion channels in mice.","date":"2021","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/34182171","citation_count":5,"is_preprint":false},{"pmid":"37760888","id":"PMC_37760888","title":"The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37760888","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54771,"output_tokens":10224,"usd":0.158836,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20571,"output_tokens":5797,"usd":0.12389,"stage2_stop_reason":"end_turn"},"total_usd":0.282726,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"Cardiac-specific, inducible knockout of HCN4 in adult mice causes severe bradycardia (~50% rate reduction), AV block, and death within ~5 days, with ~70% reduction of If current in sinoatrial node myocytes, establishing HCN4 as essential for normal cardiac impulse generation and conduction.\",\n      \"method\": \"Inducible cardiac-specific Cre-lox knockout mouse model; in vitro patch-clamp of isolated SAN myocytes; immunofluorescence and Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — cardiac-specific KO with defined electrophysiological and in vivo phenotypes, multiple orthogonal methods (patch-clamp, immunofluorescence, Western blot, telemetric ECG)\",\n      \"pmids\": [\"21220308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HCN4 and HCN1 co-assemble into heteromeric channels in heterologous expression; the HCN4-HCN1 (4-1) tandem construct produces activation kinetics intermediate between the two homomers, approaching those of native rabbit SAN If current, suggesting both isoforms contribute to native f-channels.\",\n      \"method\": \"Heterologous co-expression in HEK293 cells; tandem-linked constructs; whole-cell patch-clamp; comparison with native SAN If\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with tandem constructs in single lab; cAMP sensitivity of co-transfected channels did not fully recapitulate native channel, leaving uncertainty\",\n      \"pmids\": [\"12702747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HCN4 channels expressed in taste cells are gated by extracellular protons: lowering pH causes a dose-dependent shift in the activation curve to more positive voltages, mediating sour taste transduction.\",\n      \"method\": \"In situ hybridization; immunohistochemistry in rat vallate papilla; whole-cell patch-clamp of taste cells; voltage-clamp of HCN channels\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct electrophysiology demonstrating proton gating of HCN channels in native taste cells plus heterologous expression; published in high-impact journal with orthogonal methods\",\n      \"pmids\": [\"11675786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The D553N missense mutation in HCN4 causes a trafficking defect that reduces membrane expression and If current in a dominant-negative manner, establishing loss-of-function via protein trafficking impairment as a mechanism for sinus node dysfunction.\",\n      \"method\": \"In vitro expression in HEK293 cells; patch-clamp; biotinylation assay; Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (patch-clamp, surface biotinylation, Western blot) in single lab; mechanistic detail on trafficking defect\",\n      \"pmids\": [\"15123648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"KCNE2 co-expressed with HCN4 enhances current amplitude, slows activation kinetics, and shifts half-maximal activation to more negative voltages; the C-terminal tail of KCNE2 (but not KCNE1, KCNE3, or KCNE4) directly interacts with the C-terminal tail of HCN4 as shown by yeast two-hybrid.\",\n      \"method\": \"Co-expression in Xenopus oocytes and CHO cells; two-electrode voltage-clamp and patch-clamp; yeast two-hybrid interaction assay\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal functional and protein-interaction data with two cell systems; single lab\",\n      \"pmids\": [\"12856183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The crystal structure of the C-terminal fragment of human HCN4 (C-linker + CNBD) at 2.4 Å reveals high similarity to mouse HCN2 but with distinct residues in the β4-β5 loop that account for HCN4's ~3-fold reduced cAMP response and prolonged deactivation upon cAMP binding compared to HCN2.\",\n      \"method\": \"X-ray crystallography at 2.4 Å; mutagenesis; electrophysiology (patch-clamp)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure combined with mutagenesis and functional electrophysiology in single study; multiple orthogonal methods\",\n      \"pmids\": [\"20829353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PKA directly phosphorylates HCN4 at ≥13 sites (≥3 N-terminal, ≥10 C-terminal) identified by in vitro phosphorylation assay and mass spectrometry; a PKA regulatory site in the distal C-terminus is required for PKA-mediated shift of HCN4 voltage dependence in sinoatrial myocytes.\",\n      \"method\": \"In vitro kinase assay; mass spectrometry; PKA inhibitor experiments on isolated SAN myocytes; truncation and alanine substitution mutagenesis; patch-clamp\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation with MS site identification plus mutagenesis and native cell electrophysiology; multiple orthogonal methods in single study\",\n      \"pmids\": [\"20713547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Src tyrosine kinase forms a complex with HCN4 (co-immunoprecipitation in HEK293 cells and rat ventricular myocytes) and constitutively active Src shifts HCN4 activation to more positive voltages and accelerates kinetics, while dominant-negative Src has the opposite effect.\",\n      \"method\": \"Co-immunoprecipitation; co-transfection with constitutively active (Src529) or dominant-negative (Src296) Src in HEK293 cells; whole-cell patch-clamp\",\n      \"journal\": \"Journal of cardiovascular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP in two cell types plus functional gain/loss-of-function electrophysiology; single lab\",\n      \"pmids\": [\"16680072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Src tyrosine kinase enhances HCN4 via Tyr531: mutation Y531F largely abolishes Src-mediated positive shift of voltage dependence and increased conductance, while Y554F selectively eliminates Src-induced kinetic changes without affecting voltage-dependent activation shift.\",\n      \"method\": \"Site-directed mutagenesis of HCN4; Src inhibitor PP2; whole-cell patch-clamp in HEK293 cells; heart rate measurement in mouse model\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis identifying specific phosphorylation sites combined with functional electrophysiology; single lab, two orthogonal approaches\",\n      \"pmids\": [\"17977941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Specific residues in S1 (Leu272), the S1-S2 linker (Asn291, Thr293), and S2 (Ile308) of HCN4 determine its slower activation kinetics compared to HCN2; L272F in S1 accelerates HCN4 activation to match HCN2 speed, and I308M in S2 abolishes cAMP-dependent acceleration of activation.\",\n      \"method\": \"HCN2/4 chimeric channel analysis; site-directed mutagenesis; patch-clamp electrophysiology in heterologous expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution via chimeras and point mutagenesis with quantitative electrophysiology identifying specific residues; single lab, two orthogonal approaches\",\n      \"pmids\": [\"12813043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MEF2 transcription factor directly binds an enhancer element (CNS13) in the Hcn4 genomic locus; dominant-negative MEF2 reduces Hcn4 mRNA expression and Ih current amplitude in embryonic heart inflow tract myocytes, establishing MEF2 as a direct transcriptional activator of Hcn4.\",\n      \"method\": \"Luciferase reporter assay; EMSA; chromatin immunoprecipitation (ChIP); dominant-negative MEF2 overexpression; patch-clamp of embryonic inflow-tract myocytes\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP, EMSA, and functional electrophysiology in native cells with dominant-negative perturbation; multiple orthogonal methods\",\n      \"pmids\": [\"19477969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The NRSE motif in the HCN4 promoter binds NRSF (neuron-restrictive silencing factor); wild-type NRSE drives expression changes that match developmental and hypertrophic HCN4 expression patterns, whereas mutant NRSE constructs fail, implicating NRSF as a transcriptional repressor of HCN4.\",\n      \"method\": \"Promoter reporter assay in rat cardiac myocytes; NRSF binding confirmation; NRSE mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter assay with mutagenesis and protein-binding confirmation; single lab\",\n      \"pmids\": [\"17173866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"miR-1 directly targets the 3'-UTR of HCN4 to repress its protein expression; forced miR-1/miR-133 expression in hypertrophic cardiomyocytes prevents HCN4 overexpression, and downregulation of miR-1/miR-133 in hypertrophic hearts (linked to reduced serum-responsive factor) underlies pathological re-expression of HCN4.\",\n      \"method\": \"3'-UTR targeting confirmation; miRNA mimic transfection; miRNA-masking antisense; Western blot; patch-clamp; rat hypertrophy model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — miR-1 target validation with mimic and masking antisense, functional current measurement, in vivo hypertrophy model; replicated across multiple approaches and model systems\",\n      \"pmids\": [\"18458081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HCN4 contains a conserved caveolin-binding domain (CBD) with aromatic residues Tyr259 and Phe262 at the N-terminus; disruption of CBD reduces HCN4-caveolin-1 interaction, causes cytoplasmic channel accumulation, and abolishes sensitivity to cholesterol depletion-induced caveolar disorganization, demonstrating that CBD mediates functional interaction with caveolin-1.\",\n      \"method\": \"CBD mutagenesis (Y259S, F262V, Y259F, F262Y); co-immunoprecipitation; whole-cell patch-clamp; confocal microscopy; cholesterol depletion in CHO cells\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis combined with co-IP, functional electrophysiology, and imaging; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"22659290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"β2-adrenergic receptors form a protein complex with HCN4 via a proximal N-terminal region of HCN4; a synthetic peptide derived from this β2AR-binding domain disrupts the complex and prevents adrenergic augmentation of pacemaker currents and spontaneous contraction rates without affecting calcium current regulation.\",\n      \"method\": \"Co-immunoprecipitation; synthetic peptide disruption assay; patch-clamp; spontaneous contraction rate measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus peptide disruption functional assay; specific domain identified; single lab\",\n      \"pmids\": [\"22613709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In adult mouse myocardium, HCN2 undergoes proteolytic cleavage to a ~60 kDa C-terminally truncated form lacking the cAMP-binding domain, which co-assembles with full-length HCN4 to form heteromeric channels; these heteromers activate faster than either homomer and resemble endogenous myocardial If, with HCN4 subunit supplying cAMP-mediated regulation.\",\n      \"method\": \"Western blot with N- and C-terminal-specific antibodies; co-immunoprecipitation of endogenous cardiac channels; heterologous co-expression; patch-clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — endogenous protein co-IP from mouse heart plus reconstitution of truncated HCN2+HCN4 heteromers with functional electrophysiology; multiple orthogonal methods\",\n      \"pmids\": [\"19574228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The N-terminus of HCN4 exists as two tissue-specific isoforms (different transcription start sites), with only one present in brain and both in heart; the extended N-terminal isoform shifts activation to more negative voltages, and three positively charged residues (Arg9, Lys10, Lys22) in the N-terminus are responsible for this functional difference.\",\n      \"method\": \"RT-PCR of brain and heart mRNA; patch-clamp of HEK293 cells expressing each variant; site-directed mutagenesis of N-terminal charged residues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis identifying specific residues with functional electrophysiology; two orthogonal methods; single lab\",\n      \"pmids\": [\"21372143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The HCN4-K530N mutation in the C-linker alters heteromeric (but not homomeric) channel properties, producing a hyperpolarizing shift in half-maximal activation voltage; this is attributed to disruption of C-linker oligomerization equilibrium between tonically inhibited and activated tetrameric states.\",\n      \"method\": \"Patch-clamp of HEK293 cells expressing homomeric mutant and co-expression of mutant+WT (heteromeric); pedigree analysis\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — heteromeric vs homomeric functional comparison identifying C-linker mechanism; single lab electrophysiology\",\n      \"pmids\": [\"23178648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"cAMP-induced relief of HCN4 autoinhibition can occur in a cellular context- and isoform-specific manner without cAMP: HCN4 (but not HCN2) expressed in CHO (but not HEK) cells shows pre-relieved autoinhibition dependent on a ~300-aa distal C-terminal region (residues 719-1012), pointing to membrane-associated intracellular factors interacting with the distal C-terminus.\",\n      \"method\": \"Patch-clamp in CHO vs HEK cells; excised inside-out patches; domain truncation mutagenesis of HCN4 distal C-terminus; cAMP application\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — domain-deletion mutagenesis with excised-patch controls; isoform comparison; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23109717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-423-5p directly targets the 3'-UTR of HCN4 (luciferase reporter abolished by mutation of recognition elements); swim-training upregulates miR-423-5p and its host gene NSRP1 driven by Nkx2.5, repressing HCN4 and If in the sinus node; anti-miR-423-5p knockdown reverses training-induced bradycardia by rescuing HCN4 expression.\",\n      \"method\": \"3'-UTR luciferase reporter assay with recognition element mutation; next-generation miRNA sequencing; qRT-PCR; anti-miR knockdown in swim-trained mice; patch-clamp; chromatin immunoprecipitation for Nkx2.5\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — luciferase reporter with mutational validation, in vivo anti-miR rescue, patch-clamp, and ChIP; multiple orthogonal methods in single study\",\n      \"pmids\": [\"28821541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A local circadian clock in the sinoatrial node drives day-night rhythms in Hcn4 expression via direct BMAL1 binding sites on the Hcn4 promoter (ChIP); cardiomyocyte-specific Bmal1 knockout abolishes day-night differences in Hcn4 mRNA and intrinsic heart rate; HCN block eliminates the day-night heart rate difference in vivo and in isolated SAN.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for BMAL1 at Hcn4 promoter; cardiomyocyte-specific Bmal1 KO mice; vagotomy; in vivo/in vitro ECG recording; HCN pharmacological block; reporter bioluminescence\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP linking transcription factor to Hcn4 promoter, transgenic KO with multiple phenotypic readouts, and pharmacological confirmation; multiple orthogonal methods\",\n      \"pmids\": [\"33278629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRMP and IRAG (homologous ER transmembrane proteins) associate with HCN4 and have opposing effects: LRMP inhibits cAMP-induced depolarizing shift in voltage dependence, while IRAG depolarizes basal voltage dependence in the absence of cAMP; both effects are isoform-specific to HCN4, independent of trafficking and cAMP binding, and IRAG is highly expressed in mouse sinoatrial node.\",\n      \"method\": \"Co-expression and functional patch-clamp in heterologous cells; co-immunoprecipitation; sinoatrial node expression analysis; computer modeling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — co-IP plus patch-clamp with isoform-specificity controls and in vivo expression confirmation; multiple orthogonal methods in single study\",\n      \"pmids\": [\"32647060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Shugoshin-1 (SGO1) directly interacts with HCN4 (co-immunoprecipitation) and promotes cell-surface expression and function of HCN4, enhancing funny current; the CAID syndrome mutation p.Lys23Glu in SGO1 impairs its interaction with HCN4, reduces membrane HCN4 expression, and depresses If in patient iPSC-derived cardiomyocytes.\",\n      \"method\": \"Co-immunoprecipitation; patch-clamp; surface expression assay; patient-specific iPSC-derived cardiomyocytes; neonatal rat ventricular myocyte model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — co-IP, functional electrophysiology, and disease-relevant iPSC model; multiple orthogonal methods in single study\",\n      \"pmids\": [\"33953173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of HCN4 in complex with ivabradine at 3 Å resolution shows ivabradine bound inside the open pore inner cavity; Y507 and I511 on S6 are the molecular determinants of ivabradine binding, F510 (pointing outside the pore) indirectly contributes by controlling Y507, and C479 in the selectivity filter accelerates block kinetics; molecular dynamics show ivabradine blocks a permeating ion via electrostatic repulsion.\",\n      \"method\": \"Cryo-EM structure at 3 Å; molecular dynamics simulations; functional validation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution cryo-EM structure of drug-channel complex with MD simulations defining binding mechanism; single study with strong structural evidence\",\n      \"pmids\": [\"38917012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Sp1 transcription factor binds the core promoter regions of HCN4 and drives its transcription; siRNA knockdown of Sp1 prevents HCN4 overexpression in hypertrophic cardiomyocytes; Sp1 upregulation underlies pathological re-expression of HCN4 in ventricular hypertrophy.\",\n      \"method\": \"5'-RACE (transcription start site); luciferase reporter; siRNA knockdown of Sp1; Western blot; RT-PCR; rat hypertrophy model\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mapping plus siRNA perturbation and in vivo model; single lab, multiple methods\",\n      \"pmids\": [\"19471099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mef2c drives Hcn4 expression specifically in embryonic non-chamber and postnatal AV bundle myocardium through a conserved cis-regulatory element; HDAC inhibition expands this enhancer activity to working myocardium, and cardiac hypertrophy (causing nuclear HDAC export) ectopically activates the Hcn4 enhancer in working myocardium.\",\n      \"method\": \"Transgenic reporter mice; in vivo Mef2c-dependent enhancer analysis; HDAC inhibitor treatment; transverse aortic constriction hypertrophy model\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic reporter with Mef2c-dependence and HDAC manipulation; single lab\",\n      \"pmids\": [\"23085412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Trx2 (mitochondrial thioredoxin-2) maintains HCN4 expression in the conduction system via a mitochondrial ROS–HDAC4–MEF2C pathway: Trx2 deletion elevates HDAC4, which binds the HCN4 enhancer via MEF2, reduces histone H3 acetylation at the MEF2 site, and decreases HCN4 transcription; mitochondria-specific ROS scavenger MitoTEMPO reverses HDAC4 elevation, HCN4 reduction, and sinus bradycardia.\",\n      \"method\": \"Conduction-system-specific Trx2 KO (Hcn4-CreERT2); ChIP; qPCR and Western blot for HCN4; MitoTEMPO rescue experiment; ECG telemetry\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — conduction-system-specific KO with ChIP mapping of HDAC4/MEF2 at HCN4 enhancer and pharmacological rescue; multiple orthogonal methods\",\n      \"pmids\": [\"31751569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HCN4 co-localizes and co-immunoprecipitates with Thy1 in adult rat retinal ganglion cells, representing the first identified protein partner of HCN4 in the retina and showing that a GPI-anchored protein can complex with an HCN channel subunit.\",\n      \"method\": \"Co-immunoprecipitation with anti-Thy1 and anti-HCN4 antibodies; confocal immunohistochemistry; patch-clamp of immunopanned cells\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal co-IP from native tissue plus imaging and electrophysiology; single lab\",\n      \"pmids\": [\"22281825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HCN4 pacemaker channels attenuate parasympathetic responses in the sinoatrial node: conditional knockdown of HCN4 enhances vagal bradycardia (complete sinus pause on vagus nerve stimulation), while HCN4 overexpression attenuates vagal bradycardia during β-adrenergic stimulation; neither manipulation significantly alters the β-adrenergic response alone.\",\n      \"method\": \"Tetracycline-inducible HCN4 overexpression and knockdown mouse lines; telemetric ECG; cervical vagus nerve stimulation; in vitro single pacemaker cell patch-clamp\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — gain- and loss-of-function in same inducible system with in vivo nerve stimulation and in vitro single-cell validation; multiple orthogonal methods\",\n      \"pmids\": [\"29315578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Ectopic HCN4 expression in cortical neurons with mTOR hyperactivation drives epilepsy: HCN4 is expressed in focal cortical malformation (FCM) neurons in a TSC/FCDII mouse model, its expression is mTOR-dependent, increased intracellular cAMP preferentially drives repetitive firing via HCN4 in FCM neurons, and blocking HCN4 prevents seizures in the model.\",\n      \"method\": \"Mouse model of TSC/FCDII focal cortical malformation; pharmacological HCN4 block; cAMP manipulation; comparison of FCM vs. control pyramidal neurons; tissue from human TSC/FCDII patients (immunostaining)\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — loss-of-function pharmacological block prevents seizures, gain-of-function cAMP drives firing specifically via HCN4, mTOR-dependence established, human tissue confirmation; multiple orthogonal methods\",\n      \"pmids\": [\"33208499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HCN4 and caveolin-3 (Cav3) co-localize in adult human atrial and ventricular cardiomyocytes but not in fetal cardiomyocytes; during hESC-CM maturation, Cav3 expression increases and HCN4-Cav3 co-localization develops by ~110 days, coinciding with a shift of f-current activation to more negative (adult-like) voltages; disruption of caveolae reverses voltage dependence toward a more positive (immature) phenotype in mature cells but not fetal cells.\",\n      \"method\": \"Immunocytochemistry; qRT-PCR; patch-clamp; methyl-β-cyclodextrin caveolae disruption in hESC-CMs at different maturation stages\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-localization with functional electrophysiology and pharmacological disruption across developmental stages; single lab\",\n      \"pmids\": [\"23311301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Coxsackievirus B3 (CVB3) reduces HCN4 plasma membrane density in hiPSC-derived pacemaker-like cells by promoting autophagosomal HCN4 insertion via Rab7-dependent endocytic trafficking; individual CVB3 proteins 2C and 3A have the most potent effects on HCN4 activity, and pharmacological Rab7 inhibition or CVB3-3A inhibition (GW5074) rescues cytoplasmic HCN4 accumulation.\",\n      \"method\": \"hiPSC-derived pacemaker cells with inducible CVB3 expression; patch-clamp; immunofluorescence of HCN4 distribution; autophagosome assay; pharmacological rescue with Rab7 inhibitor and GW5074\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (Rab7/autophagosome) identified with pharmacological rescue; multiple methods; single lab\",\n      \"pmids\": [\"35864219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A gain-of-function mutation p.V240M in the HCN domain (N-terminus) of HCN4 causes inappropriate sinus tachycardia by increasing single-channel conductance, opening frequency, and opening probability without altering cAMP sensitivity or membrane expression; the HCN domain therefore stabilizes the channel in the closed state.\",\n      \"method\": \"Macroscopic and single-channel patch-clamp in cells expressing WT and/or p.V240M HCN4; cell surface expression assay; computer simulation of sinoatrial node\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-channel recordings plus macroscopic current, surface expression, and computational modeling; multiple orthogonal methods in single study\",\n      \"pmids\": [\"38032931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Molecular dynamics simulations of the HCN4 selectivity filter reveal two K+ binding sites and one Na+ binding site; Na+ acts as a weak blocker released by K+-induced filter widening, Li+ cannot enter the filter due to incomplete coordination, and Cs+ preferentially occupies the S3-equivalent site to block conduction, explaining weak cation selectivity.\",\n      \"method\": \"Molecular dynamics simulations of open HCN4 pore; comparison with experimental conductance data (Li+, Rb+, Cs+)\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — computational simulations recapitulating experimental ion selectivity data; no structural or mutagenesis validation in same paper\",\n      \"pmids\": [\"37523352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Testosterone recruits the androgen receptor (AR) to regulatory regions of the HCN4 gene (confirmed by ChIP), associated with increased histone acetylation, upregulating HCN4 expression during cardiomyogenesis; AR knockdown or anti-androgenic treatment inhibits this effect.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for AR at HCN4 regulatory region; AR knockdown; histone acetylation analysis; RT-PCR and Western blot in mES and P19 cells\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifying AR binding at HCN4 locus plus loss-of-function; single lab\",\n      \"pmids\": [\"23598283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Notch1 signaling induces re-expression of HCN4 in mature cardiomyocytes via a regulatory complex of NICD and KDM5A (a histone demethylase) that targets the HCN4 promoter, promotes histone demethylation, and drives aconitine-induced ventricular arrhythmia; Notch1 inhibition reverses these changes.\",\n      \"method\": \"Co-immunoprecipitation of NICD-KDM5A complex; ChIP at HCN4 promoter; patch-clamp of beating rate; pharmacological Notch1 inhibitor rescue; human and rat cardiomyocytes\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of regulatory complex plus ChIP at HCN4 promoter with pharmacological rescue; single lab\",\n      \"pmids\": [\"32234357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cfp1 (CXXC finger protein 1) maintains HCN4 expression by binding the HCN4 promoter and maintaining H3K4 trimethylation, H3K9 acetylation, and H3K27 acetylation; Cfp1 heterozygous knockout reduces these histone marks, decreases HCN4 protein, and reduces If density by 66% in SAN cells, causing mild bradycardia.\",\n      \"method\": \"Cfp1 heterozygous KO mice (Hcn4-CreERT2 line); ChIP in HL-1 cells for H3K4me3, H3K9ac, H3K27ac at HCN4 promoter; patch-clamp; qPCR; Western blot\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP for multiple histone marks at HCN4 promoter plus patch-clamp and conduction-system-specific KO; multiple orthogonal methods\",\n      \"pmids\": [\"34182171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The G480R mutation in the HCN4 pore domain causes familial sinus bradycardia through two mechanisms: reduced channel synthesis, a trafficking defect reducing plasma membrane expression (assessed by biotinylation/Western blot), and a shift of activation to more negative voltages.\",\n      \"method\": \"Sequencing; expression in Xenopus oocytes and HEK293 cells; patch-clamp; surface biotinylation; Western blot\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary functional assays plus surface expression quantification; single lab\",\n      \"pmids\": [\"17646576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HCN4-expressing enteric neurons in zebrafish specifically regulate retrograde (but not anterograde) peristalsis: HCN channel block or morpholino knockdown selectively attenuates retrograde peristalsis, while optogenetic activation of HCN4+ neurons (channelrhodopsin) selectively enhances retrograde peristalsis.\",\n      \"method\": \"Forward genetics in zebrafish; HCN channel pharmacological block; morpholino knockdown; optogenetic activation of HCN4+ neurons expressing channelrhodopsin; peristalsis measurement\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — forward genetics discovery plus orthogonal loss- and gain-of-function (pharmacology, morpholino, optogenetics) with specific functional readout\",\n      \"pmids\": [\"32130893\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HCN4 is the principal pore-forming subunit of the cardiac 'funny' (If) pacemaker current, a hyperpolarization-activated, cAMP-regulated cation channel whose gating is governed by its CNBD/C-linker (crystal structure solved), N-terminal HCN domain, and S1-S2-S6 transmembrane segments; it is activated at diastolic membrane potentials, modulated by direct cAMP binding (relieving C-linker autoinhibition), PKA phosphorylation at multiple C-terminal sites, Src tyrosine kinase (via Tyr531), caveolin-1 (via an N-terminal CBD), KCNE2 and LRMP/IRAG auxiliary subunits, and β2-adrenergic receptor co-complexes, while its transcription is controlled by MEF2C/HDAC, NRSF, Sp1, BMAL1 (circadian clock), and post-transcriptionally by miR-1 and miR-423-5p; cardiac-specific knockout in adult mice produces severe bradycardia and AV block, establishing its essential role in sinoatrial pacemaking, and ectopic HCN4 expression in mTOR-activated cortical neurons drives epilepsy via a cAMP-dependent mechanism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HCN4 is the principal pore-forming subunit of the cardiac hyperpolarization-activated 'funny' (If) pacemaker current, and its activity is essential for sinoatrial impulse generation and conduction: inducible cardiac-specific knockout in adult mice produces severe bradycardia, AV block, and death with profound loss of SAN If current [#0]. The channel is a weakly selective cation conductance whose gating is set by defined structural modules — N-terminal HCN domain residues that stabilize the closed state (a gain-of-function p.V240M mutation increases open probability and conductance to cause inappropriate sinus tachycardia) [#32], S1/S1-S2/S2 residues that tune activation kinetics relative to HCN2 [#9], and a C-linker/CNBD whose crystal structure explains HCN4's attenuated cAMP response relative to HCN2 [#5], with cAMP binding relieving C-linker autoinhibition in an isoform- and context-dependent manner [#18]. cAMP-dependent regulation underlies its physiological roles in autonomic heart-rate control, where HCN4 attenuates parasympathetic (vagal) bradycardia [#28], and in disease, where ectopic HCN4 in mTOR-hyperactivated cortical neurons drives cAMP-dependent repetitive firing and seizures [#29]. Channel function is shaped by an array of direct partners and modulators: PKA phosphorylates HCN4 at multiple C-terminal sites to shift voltage dependence [#6], Src tyrosine kinase enhances the current via Tyr531 [#7, #8], the auxiliary subunit KCNE2 [#4] and the ER proteins LRMP and IRAG exert opposing isoform-specific effects on cAMP-dependent gating [#21], caveolin-1 binding through an N-terminal CBD controls localization [#13], and β2-adrenergic receptors form an N-terminal co-complex required for adrenergic augmentation of pacemaking [#14]. Trafficking and surface density are governed by SGO1, whose CAID-syndrome mutation impairs HCN4 membrane expression [#22], and are disrupted by trafficking-defective disease mutations (D553N, G480R) [#3, #37] and by coxsackievirus-driven Rab7-dependent internalization [#31]. HCN4 transcription is tightly controlled by MEF2C acting through a conserved enhancer (modulated by HDAC export and a mitochondrial Trx2–ROS–HDAC4 axis) [#10, #25, #26], by Sp1 [#24], NRSF [#11], the circadian factor BMAL1 driving day-night heart-rate rhythms [#20], and chromatin regulators including Cfp1 [#36], while miR-1 and miR-423-5p repress it post-transcriptionally during hypertrophy and exercise training [#12, #19]. The channel is also the molecular target of the bradycardic drug ivabradine, which binds the open-pore inner cavity via S6 residues Y507 and I511 [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Establishing that HCN4 channels could be gated by extracellular protons defined a sensory-transduction role beyond simple voltage-dependent pacemaking.\",\n      \"evidence\": \"In situ hybridization and patch-clamp of native taste cells plus heterologous HCN expression\",\n      \"pmids\": [\"11675786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the cardiac pacemaker role\", \"Molecular site of proton gating not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Chimera and mutagenesis work answered which residues set HCN4's characteristically slow activation, mapping kinetic determinants to S1, the S1-S2 linker, and S2.\",\n      \"evidence\": \"HCN2/4 chimeras and point mutagenesis with patch-clamp in heterologous cells\",\n      \"pmids\": [\"12813043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis not resolved\", \"Did not address native heteromeric channels\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Co-assembly studies addressed the subunit composition of native f-channels, showing HCN4-HCN1 heteromers and KCNE2 association reshape gating toward native SAN If.\",\n      \"evidence\": \"Tandem-construct and co-expression patch-clamp plus yeast two-hybrid for KCNE2\",\n      \"pmids\": [\"12702747\", \"12856183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"cAMP sensitivity of heteromers did not fully match native current\", \"Stoichiometry in vivo unresolved\", \"KCNE2 interaction shown only by Y2H, not in native tissue\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The first disease mutation (D553N) defined trafficking impairment as a dominant-negative loss-of-function mechanism for sinus node dysfunction.\",\n      \"evidence\": \"HEK293 expression with patch-clamp, surface biotinylation, and Western blot\",\n      \"pmids\": [\"15123648\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Trafficking machinery involved not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Endogenous co-IP from heart resolved how native myocardial If arises, showing a cleaved cAMP-insensitive HCN2 fragment heteromerizes with full-length HCN4.\",\n      \"evidence\": \"Antibody-specific Western blot, co-IP of cardiac channels, and reconstitution patch-clamp\",\n      \"pmids\": [\"19574228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease responsible for HCN2 cleavage unknown\", \"Physiological relevance of heteromers in pacemaking not quantified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Structural and biochemical work defined cAMP regulation, with the C-linker/CNBD crystal structure explaining HCN4's reduced cAMP response and mass spectrometry mapping PKA phosphorylation sites controlling voltage dependence.\",\n      \"evidence\": \"2.4 Å X-ray crystallography with mutagenesis, plus in vitro kinase/MS and SAN myocyte patch-clamp\",\n      \"pmids\": [\"20829353\", \"20713547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length channel structure absent\", \"How distinct PKA sites integrate not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of N-terminal partner domains established how HCN4 is localized and adrenergically tuned, via a caveolin-1-binding CBD and a β2AR co-complex domain.\",\n      \"evidence\": \"Mutagenesis, co-IP, peptide disruption, patch-clamp, and confocal imaging\",\n      \"pmids\": [\"22659290\", \"22613709\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab for each interaction\", \"Structural detail of complexes lacking\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Studies of N-terminal isoforms, a C-linker disease mutation, and context-dependent autoinhibition relief defined how intracellular regions modulate basal and cAMP-dependent gating.\",\n      \"evidence\": \"RT-PCR isoform mapping, mutagenesis, and excised-patch electrophysiology in CHO vs HEK cells\",\n      \"pmids\": [\"21372143\", \"23178648\", \"23109717\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The membrane-associated factor relieving autoinhibition in CHO cells unidentified\", \"K530N heteromeric mechanism inferred indirectly\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Src kinase was established as a direct positive modulator, with Tyr531 and Tyr554 dissecting voltage-shift versus kinetic effects.\",\n      \"evidence\": \"Co-IP in two cell types, constitutively active/dominant-negative Src, site-directed mutagenesis, and patch-clamp\",\n      \"pmids\": [\"16680072\", \"17977941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance of Src tyrosine phosphorylation not fully established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Transcriptional control was defined through MEF2 binding a conserved Hcn4 enhancer and Sp1 driving the core promoter, including pathological re-expression in hypertrophy.\",\n      \"evidence\": \"ChIP, EMSA, luciferase reporters, dominant-negative MEF2, Sp1 siRNA, and patch-clamp\",\n      \"pmids\": [\"19477969\", \"19471099\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Combinatorial control with other factors unresolved\", \"Direct MEF2 vs Sp1 hierarchy not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Post-transcriptional repression by miR-1 was established as a mechanism preventing pathological HCN4 overexpression in hypertrophy.\",\n      \"evidence\": \"3'-UTR targeting, mimic and masking antisense, Western blot, patch-clamp, and rat hypertrophy model\",\n      \"pmids\": [\"18458081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution vs transcriptional control unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Cardiac-specific inducible knockout definitively established HCN4 as essential for adult cardiac impulse generation and conduction.\",\n      \"evidence\": \"Inducible cardiac Cre-lox KO with SAN patch-clamp, immunofluorescence, and telemetric ECG\",\n      \"pmids\": [\"21220308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not dissect SAN vs AV-node contributions mechanistically\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Gain- and loss-of-function in the same inducible system revealed that HCN4 buffers parasympathetic (vagal) bradycardia in the SAN.\",\n      \"evidence\": \"Tetracycline-inducible HCN4 overexpression/knockdown mice with in vivo vagal stimulation and single-cell patch-clamp\",\n      \"pmids\": [\"29315578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between If and cholinergic signaling not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Auxiliary ER proteins LRMP and IRAG were identified as isoform-specific, oppositely-acting modulators of HCN4 cAMP-dependent gating, with IRAG enriched in SAN.\",\n      \"evidence\": \"Co-expression patch-clamp, co-IP, SAN expression analysis, and modeling\",\n      \"pmids\": [\"32647060\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of opposing effects unknown\", \"Physiological IRAG/LRMP balance in vivo not measured\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Circadian and metabolic transcriptional axes were established: BMAL1 directly drives day-night Hcn4 rhythms and a mitochondrial Trx2-ROS-HDAC4-MEF2C pathway maintains conduction-system HCN4.\",\n      \"evidence\": \"ChIP, cardiomyocyte/conduction-system-specific KO mice, pharmacological rescue (MitoTEMPO, HCN block), and ECG\",\n      \"pmids\": [\"33278629\", \"31751569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between circadian and ROS-driven control not integrated\", \"Upstream signals coupling metabolism to HDAC4 incompletely mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Ectopic HCN4 was shown to be pathogenic outside the heart, driving cAMP-dependent epileptic firing in mTOR-hyperactivated cortical neurons.\",\n      \"evidence\": \"TSC/FCDII mouse model, pharmacological HCN4 block, cAMP manipulation, and human tissue immunostaining\",\n      \"pmids\": [\"33208499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional mechanism of mTOR-driven HCN4 induction not fully defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Trafficking partners and chromatin regulators were identified: SGO1 promotes HCN4 surface expression (disrupted in CAID syndrome) and Cfp1 maintains activating histone marks at the HCN4 promoter.\",\n      \"evidence\": \"Co-IP, surface assays, patient iPSC-CMs, ChIP for histone marks, and patch-clamp in conduction-system-specific KO\",\n      \"pmids\": [\"33953173\", \"34182171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of SGO1-mediated surface delivery not resolved\", \"Direct vs indirect Cfp1 effects on HCN4 not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Single-channel analysis of a gain-of-function HCN-domain mutation (p.V240M) established that the N-terminal HCN domain stabilizes the closed state, linking inappropriate sinus tachycardia to increased open probability.\",\n      \"evidence\": \"Macroscopic and single-channel patch-clamp, surface expression assay, and SAN computer modeling\",\n      \"pmids\": [\"38032931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism of HCN-domain closed-state stabilization not visualized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Atomic-resolution structure defined the pharmacological target site, showing ivabradine blocks the open-pore inner cavity via S6 residues Y507 and I511.\",\n      \"evidence\": \"3 Å cryo-EM of the HCN4-ivabradine complex with molecular dynamics and functional validation\",\n      \"pmids\": [\"38917012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full gating-cycle structures still lacking\", \"Ion-selectivity mechanism addressed only computationally [#33]\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many transcriptional, post-transcriptional, phosphorylation, trafficking, and auxiliary-subunit inputs are integrated to set beat-to-beat If in vivo, and the full-length channel gating-cycle structure, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length apo/cAMP-bound HCN4 structure across gating states\", \"Quantitative hierarchy of regulators in native SAN unknown\", \"Ion selectivity mechanism not experimentally validated by structure/mutagenesis\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 9, 33]},\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [0, 33]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [5, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 13, 22, 37]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10, 24, 20, 25]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [0, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 14, 18]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [29, 38]}\n    ],\n    \"complexes\": [\n      \"HCN4-HCN1 heteromeric channel\",\n      \"HCN4-cleaved HCN2 heteromeric channel\",\n      \"HCN4-β2AR co-complex\"\n    ],\n    \"partners\": [\n      \"KCNE2\",\n      \"SRC\",\n      \"CAV1\",\n      \"ADRB2\",\n      \"LRMP\",\n      \"IRAG\",\n      \"SGO1\",\n      \"THY1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}